Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 13NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Head & Neck 1CNS 1

Conditions

Breast Neoplasms 22Stomach Neoplasms 3Inflammatory Breast Neoplasms 3Sarcoma 2Ovarian Neoplasms 2Neuroectodermal Tumors, Primitive, Peripheral 2Malignant mesenchymal tumor 2Lymphoma 2Liver Neoplasms 2Liposarcoma 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2Fibrosarcoma 2Esophageal Neoplasms 2Desmoplastic Small Round Cell Tumor 2Carcinoma, Hepatocellular 2Breast Neoplasms, Male 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Neoplasms, Unknown Primary 1Lung Neoplasms 1Hodgkin Disease 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Esthesioneuroblastoma, Olfactory 1Endometrial Neoplasms 1

Interventions

Doxorubicin 9Specimen Handling 7Sorafenib 7Erlotinib Hydrochloride 7Oxaliplatin 6Magnetic Resonance Spectroscopy 6Leucovorin 6Fluorouracil 5Thalidomide 4Radiofrequency Ablation 4Bevacizumab 4tremelimumab 3cediranib 3cabozantinib 3Trastuzumab 3Pharmacogenomic Testing 3Nivolumab 3Neoadjuvant Therapy 3Melphalan 3MK 2206 3Irinotecan 3Fluorodeoxyglucose F18 3Dasatinib 3Cisplatin 3Chemotherapy, Adjuvant 3Bortezomib 3Biopsy 3AZD 6244 3trametinib 2sargramostim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Carcinoma, Hepatocellular × Epirubicin × Clear all
NCT00058487 2013-07-18

Epirubicin and Thalidomide in Treating Patients With Liver Cancer

National Cancer Institute (NCI)

Phase 2 Completed
12 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00021047 2012-03-08

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
CNSGastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Bile Duct Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡